Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Clinical Trial of Fludrocortisone for Vasovagal Syncope: The Second Prevention of Syncope Trial (POST II)

NCT00118482 is registered in ClinicalTrials.gov with University of Calgary as lead sponsor.

NCT NCT00118482
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00118482 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Clinical Trial of Fludrocortisone for Vasovagal Syncope: The Second Prevention of Syncope Trial (POST II)
Lead sponsor
University of Calgary
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2005
Completion date
July 31, 2011
Enrollment
213 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

syncope, vasovagal, neurally-mediated